Company / Free Cash Flow per Share
Vir Biotechnology, Inc. Free Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.90
FY2025
5-year range
-$6.01 / -$1.09
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
#148 of 192
Health Care
What the data says
Vir Biotechnology, Inc.'s free cash flow per share of $-2.90 is lower than 77% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-32.12 in FY2017 to $-1.09 in FY2021.
Based on SEC 10-K filings.
-2.90 in FY2025.
Improved from $-6.01 to $-2.90 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 192This company -$2.90 Sector average -$19.84
▼
+85.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 14.0% year-over-year.
- Ranks #148 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.90 | +14.0% |
| FY2024 | -$3.37 | +44.0% |
| FY2023 | -$6.01 | -299.0% |
| FY2022 | -$1.51 | -38.4% |
| FY2021 | -$1.09 | +40.7% |
| FY2020 | -$1.83 | +88.3% |
| FY2019 | -$15.64 | -17.2% |
| FY2018 | -$13.34 | +58.5% |
| FY2017 | -$32.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026